기질 혈관 분획(SVF) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Stromal Vascular Fraction Market - Scope of Report

TMR's report on the global stromal vascular fraction market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global stromal vascular fraction market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stromal vascular fraction market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the stromal vascular fraction market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stromal vascular fraction market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stromal vascular fraction market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stromal vascular fraction market.

The report delves into the competitive landscape of the global stromal vascular fraction market. Key players operating in the global stromal vascular fraction market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stromal vascular fraction market profiled in this report.

Key Questions Answered in Global stromal vascular fraction Market Report:

• What is the sales/revenue generated by stromal vascular fraction across all regions during the forecast period?
• What are the opportunities in the global stromal vascular fraction market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Stromal Vascular Fraction Market - Research Objectives and Research Approach

The comprehensive report on the global stromal vascular fraction market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stromal vascular fraction market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stromal vascular fraction market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stromal Vascular Fraction Market

4. Market Overview

• 4.1. Introduction
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Stromal Vascular Fraction Market Analysis and Forecasts, 2020-2034
• 4.5. Porter's Five Force Analysis

5. Key Insights

• 5.1. Value Chain Analysis
• 5.2. Porters Five Forces of Analysis
• 5.3. Key Industry Events
• 5.4. Regulatory Scenario by Global/Regional

6. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product, 2020-2034
  • 6.3.1. Instruments
  • 6.3.2. Kits and Reagents
  • 6.3.3. Others
• 6.4. Market Attractiveness By Product

7. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Method

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Method, 2020-2034
  • 7.3.1. Aspiation
  • 7.3.2. Transfer
  • 7.3.3. Isolation
    • 7.3.3.1. Enzymatic
    • 7.3.3.2. Non-Enzymatic
• 7.4. Market Attractiveness By Method

8. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Application

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Application, 2020-2034
  • 8.3.1. Cosmetic Application
  • 8.3.2. Orthopedic Application
  • 8.3.3. Soft Tissue Application
  • 8.3.4. Others
• 8.4. Market Attractiveness By Application

9. Global Stromal Vascular Fraction Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2020-2034
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Attractiveness By End-user

10. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Country/Region

11. North America Stromal Vascular Fraction Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product , 2020-2034
  • 11.2.1. Instruments
  • 11.2.2. Kits and Reagents
  • 11.2.3. Others
• 11.3. Market Value Forecast By Method, 2020-2034
  • 11.3.1. Aspiration
  • 11.3.2. Transfer
  • 11.3.3. Isolation
    • 11.3.3.1. Enzymatic
    • 11.3.3.2. Non-Enzymatic
• 11.4. Market Value Forecast By Application, 2020-2034
  • 11.4.1. Cosmetic Application
  • 11.4.2. Orthopedic Application
  • 11.4.3. Soft Tissue Application
  • 11.4.4. Others
• 11.5. Market Value Forecast By End-user, 2020-2034
  • 11.5.1. Hospitals
  • 11.5.2. Specialty Clinics
  • 11.5.3. Others
• 11.6. Market Value Forecast By Country, 2020-2034
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product
  • 11.7.2. By Method
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Stromal Vascular Fraction Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product , 2020-2034
  • 12.2.1. Instruments
  • 12.2.2. Kits and Reagents
  • 12.2.3. Others
• 12.3. Market Value Forecast By Method, 2020-2034
  • 12.3.1. Aspiration
  • 12.3.2. Transfer
  • 12.3.3. Isolation
    • 12.3.3.1. Enzymatic
    • 12.3.3.2. Non-Enzymatic
• 12.4. Market Value Forecast By Application, 2020-2034
  • 12.4.1. Cosmetic Application
  • 12.4.2. Orthopedic Application
  • 12.4.3. Soft Tissue Application
  • 12.4.4. Others
• 12.5. Market Value Forecast By End-user, 2020-2034
  • 12.5.1. Hospitals
  • 12.5.2. Specialty Clinics
  • 12.5.3. Others
• 12.6. Market Value Forecast By Country, 2020-2034
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Spain
  • 12.6.5. Italy
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product
  • 12.7.2. By Method
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country

13. Asia Pacific Stromal Vascular Fraction Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product , 2020-2034
  • 13.2.1. Instruments
  • 13.2.2. Kits and Reagents
  • 13.2.3. Others
• 13.3. Market Value Forecast By Method, 2020-2034
  • 13.3.1. Aspiration
  • 13.3.2. Transfer
  • 13.3.3. Isolation
    • 13.3.3.1. Enzymatic
    • 13.3.3.2. Non-Enzymatic
• 13.4. Market Value Forecast By Application, 2020-2034
  • 13.4.1. Cosmetic Application
  • 13.4.2. Orthopedic Application
  • 13.4.3. Soft Tissue Application
  • 13.4.4. Others
• 13.5. Market Value Forecast By End-user, 2020-2034
  • 13.5.1. Hospitals
  • 13.5.2. Specialty Clinics
  • 13.5.3. Others
• 13.6. Market Value Forecast By Country, 2020-2034
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product
  • 13.7.2. By Method
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country

14. Latin America Stromal Vascular Fraction Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product , 2020-2034
  • 14.2.1. Instruments
  • 14.2.2. Kits and Reagents
  • 14.2.3. Others
• 14.3. Market Value Forecast By Method, 2020-2034
  • 14.3.1. Aspiration
  • 14.3.2. Transfer
  • 14.3.3. Isolation
    • 14.3.3.1. Enzymatic
    • 14.3.3.2. Non-Enzymatic
• 14.4. Market Value Forecast By Application, 2020-2034
  • 14.4.1. Cosmetic Application
  • 14.4.2. Orthopedic Application
  • 14.4.3. Soft Tissue Application
  • 14.4.4. Others
• 14.5. Market Value Forecast By End-user, 2020-2034
  • 14.5.1. Hospitals
  • 14.5.2. Specialty Clinics
  • 14.5.3. Others
• 14.6. Market Value Forecast By Country, 2020-2034
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product
  • 14.7.2. By Method
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country

15. Middle East & Africa Stromal Vascular Fraction Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product , 2020-2034
  • 15.2.1. Instruments
  • 15.2.2. Kits and Reagents
  • 15.2.3. Others
• 15.3. Market Value Forecast By Method, 2020-2034
  • 15.3.1. Aspiration
  • 15.3.2. Transfer
  • 15.3.3. Isolation
    • 15.3.3.1. Enzymatic
    • 15.3.3.2. Non-Enzymatic
• 15.4. Market Value Forecast By Application, 2020-2034
  • 15.4.1. Cosmetic Application
  • 15.4.2. Orthopedic Application
  • 15.4.3. Soft Tissue Application
  • 15.4.4. Others
• 15.5. Market Value Forecast By End-user, 2020-2034
  • 15.5.1. Hospitals
  • 15.5.2. Specialty Clinics
  • 15.5.3. Others
• 15.6. Market Value Forecast By Country, 2020-2034
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product
  • 15.7.2. By Method
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2022)
• 16.3. Company Profiles
  • 16.3.1. Plus Therapeutics Inc.
    • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.1.2. Product Portfolio
    • 16.3.1.3. Financial Overview
    • 16.3.1.4. SWOT Analysis
    • 16.3.1.5. Strategic Overview
  • 16.3.2. GE Healthcare (Biosafe Gp SA) (Cytiva)
    • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.2.2. Product Portfolio
    • 16.3.2.3. Financial Overview
    • 16.3.2.4. SWOT Analysis
    • 16.3.2.5. Strategic Overview
  • 16.3.3. Tissue Genesis Inc.
    • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.3.2. Product Portfolio
    • 16.3.3.3. Financial Overview
    • 16.3.3.4. SWOT Analysis
    • 16.3.3.5. Strategic Overview
  • 16.3.4. Human Med AG Inc.
    • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.4.2. Product Portfolio
    • 16.3.4.3. Financial Overview
    • 16.3.4.4. SWOT Analysis
    • 16.3.4.5. Strategic Overview
  • 16.3.5. InGeneron, Inc.
    • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.5.2. Product Portfolio
    • 16.3.5.3. Financial Overview
    • 16.3.5.4. SWOT Analysis
    • 16.3.5.5. Strategic Overview
  • 16.3.6. Allergen PLC (Abbvie)
    • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.6.2. Product Portfolio
    • 16.3.6.3. Financial Overview
    • 16.3.6.4. SWOT Analysis
    • 16.3.6.5. Strategic Overview
  • 16.3.7. GID Group, Inc.
    • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.7.2. Product Portfolio
    • 16.3.7.3. Financial Overview
    • 16.3.7.4. SWOT Analysis
    • 16.3.7.5. Strategic Overview
  • 16.3.8. Bimini Health Tech
    • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.8.2. Product Portfolio
    • 16.3.8.3. Financial Overview
    • 16.3.8.4. SWOT Analysis
    • 16.3.8.5. Strategic Overview
  • 16.3.9. Laboratorios Fidia Farmaceutica S.L.U.
    • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.9.2. Product Portfolio
    • 16.3.9.3. Financial Overview
    • 16.3.9.4. SWOT Analysis
    • 16.3.9.5. Strategic Overview